Alberto Martini Selected Research

autosomal dominant familial Periodic fever

1/2017	Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study.
6/2013	Autophagy contributes to inflammation in patients with TNFR-associated periodic syndrome (TRAPS).
5/2013	Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review.
7/2011	Candidate genes in patients with autoinflammatory syndrome resembling tumor necrosis factor receptor-associated periodic syndrome without mutations in the TNFRSF1A gene.
3/2006	Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: pathogenetic and clinical implications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alberto Martini Research Topics

Disease

88	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2024 - 01/2002
47	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 06/2018
39	Neoplasms (Cancer) 03/2024 - 06/2014
25	Arthritis (Polyarthritis) 05/2023 - 05/2003
18	Urinary Bladder Neoplasms (Bladder Cancer) 02/2024 - 01/2017
18	Inflammation (Inflammations) 01/2023 - 10/2002
15	Carcinoma (Carcinomatosis) 02/2024 - 10/2019
14	Dermatomyositis (Dermatopolymyositis) 05/2019 - 11/2002
12	Fever (Fevers) 12/2020 - 03/2005
11	Infections 11/2021 - 12/2012
11	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2020 - 09/2004
11	Cryopyrin-Associated Periodic Syndromes 01/2020 - 09/2007
9	Pericarditis 10/2020 - 01/2009
8	Necrosis 11/2022 - 08/2008
8	Pain (Aches) 01/2021 - 12/2006
7	Psoriatic Arthritis 05/2023 - 01/2011
7	Renal Cell Carcinoma (Grawitz Tumor) 11/2022 - 03/2019
7	Body Weight (Weight, Body) 01/2021 - 02/2005
6	Rheumatic Diseases (Rheumatism) 12/2020 - 01/2008
6	Familial Mediterranean Fever (Periodic Disease) 01/2019 - 05/2008
5	Margins of Excision 12/2023 - 01/2019
5	Mevalonate Kinase Deficiency 01/2022 - 05/2008
5	Rheumatoid Arthritis 10/2021 - 06/2015
5	autosomal dominant familial Periodic fever 01/2017 - 03/2006
5	Macrophage Activation Syndrome 01/2016 - 12/2012
5	Lupus Nephritis 08/2015 - 11/2012
4	Acute Kidney Injury (Acute Renal Failure) 10/2022 - 12/2018
4	Kidney Neoplasms (Kidney Cancer) 02/2022 - 12/2018
4	Proteinuria 08/2015 - 05/2010
4	Myositis (Idiopathic Inflammatory Myopathies) 05/2015 - 11/2002
4	Iridocyclitis 01/2015 - 03/2005
3	Non-Muscle Invasive Bladder Neoplasms 02/2024 - 01/2022
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2021
3	Disease Progression 01/2022 - 09/2014
3	Chronic Renal Insufficiency 07/2021 - 01/2019
3	Lymphadenitis (Adenitis) 04/2018 - 05/2013
3	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 10/2002
3	Pyogenic arthritis, pyoderma gangrenosum, and acne 01/2016 - 05/2013
3	Synovitis 07/2013 - 01/2010
3	Joint Diseases (Joint Disease) 12/2007 - 03/2005
2	Frailty 01/2023 - 01/2022

Drug/Important Bio-Agent (IBA)

22	Methotrexate (Mexate)FDA LinkGeneric 11/2023 - 07/2004
13	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2023 - 08/2003
12	Abatacept (Orencia)FDA Link 01/2024 - 08/2008
10	C-Reactive ProteinIBA 11/2023 - 12/2006
10	canakinumab FDA Link 01/2022 - 02/2012
10	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2018 - 09/2007
9	GlucocorticoidsIBA 01/2021 - 05/2003
9	Interleukin-1 (Interleukin 1)IBA 09/2018 - 09/2007
9	Proteins (Proteins, Gene)FDA Link 01/2017 - 10/2002
8	Biomarkers (Surrogate Marker)IBA 07/2022 - 12/2012
7	Antinuclear AntibodiesIBA 01/2019 - 08/2003
6	Etanercept (Enbrel)FDA Link 05/2023 - 02/2013
6	tocilizumab (atlizumab)FDA Link 10/2021 - 12/2012
6	Antirheumatic Agents (DMARD)IBA 02/2020 - 08/2008
6	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2018 - 09/2007
6	InterleukinsIBA 11/2016 - 07/2003
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2011 - 03/2006
5	Prostate-Specific Antigen (Semenogelase)IBA 12/2023 - 10/2020
5	Hormones (Hormone)IBA 06/2023 - 12/2020
5	pembrolizumabIBA 11/2022 - 01/2022
5	AntigensIBA 10/2022 - 10/2002
5	ametantrone (HAQ)IBA 01/2021 - 05/2003
5	Colchicine FDA LinkGeneric 10/2020 - 06/2014
5	CytokinesIBA 01/2020 - 10/2004
5	AntibodiesIBA 12/2019 - 09/2010
5	AutoantibodiesIBA 08/2015 - 09/2010
4	Immune Checkpoint InhibitorsIBA 07/2023 - 11/2019
4	Prednisone (Sone)FDA LinkGeneric 06/2023 - 01/2015
4	Rheumatoid FactorIBA 11/2021 - 03/2005
3	AndrogensIBA 06/2023 - 11/2022
3	tofacitinibIBA 01/2022 - 12/2017
3	Adalimumab (Humira)FDA Link 10/2020 - 08/2008
3	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2019 - 05/2008
3	DNA (Deoxyribonucleic Acid)IBA 08/2015 - 09/2010
3	Interleukin-6 (Interleukin 6)IBA 05/2014 - 06/2011
3	Infliximab (Remicade)FDA Link 09/2010 - 09/2007
3	Interleukin-1beta (Interleukin 1 beta)IBA 11/2009 - 09/2007
3	EpitopesIBA 05/2007 - 10/2002
2	PlatinumIBA 01/2024 - 12/2019
2	amsonic acid (DAS)IBA 01/2024 - 10/2018
2	olaparibIBA 10/2023 - 06/2023
2	atezolizumabIBA 07/2023 - 03/2022
2	InterferonsIBA 01/2023 - 09/2010
2	Docetaxel (Taxotere)FDA Link 11/2022 - 01/2021

Therapy/Procedure

50	Therapeutics 01/2024 - 08/2003
30	Prostatectomy (Retropubic Prostatectomy) 01/2024 - 01/2017
13	Nephrectomy 01/2023 - 11/2016
12	Immunotherapy 03/2024 - 11/2019
11	Cystectomy 02/2024 - 01/2017
8	Drug Therapy (Chemotherapy) 01/2024 - 01/2011
7	Nephroureterectomy 02/2024 - 11/2020
7	Castration 10/2023 - 01/2021
6	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 06/2018
5	Neoadjuvant Therapy 01/2022 - 08/2018
5	Injections 01/2018 - 08/2003
4	Conservative Treatment 02/2024 - 03/2016
3	Radiotherapy 01/2023 - 01/2020
2	Salvage Therapy 06/2023 - 12/2021
2	Adjuvant Chemotherapy 01/2022 - 01/2020